Camallergy
UK - CambridgeBiotechnology
Focus: Camallergy is a UK-based biotechnology company specializing in allergy immunotherapy, headquartered in Cambridge. The company appears to operate primarily in generics/post-LOE products with a focus on metabolic disease applications.
Profile data last refreshed 21h ago · AI intelligence enriched 2w ago
Open Jobs
0
About Camallergy
AI assessmentNot HiringNo open roles listed right now. Follow Camallergy to get notified when they start hiring — the background below is worth knowing for when they do.
Generated by Claude from Camallergy's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Data completeness
2/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
1 in 5yr
SUPRENZA
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
Post-LOE
Post-loss-of-exclusivity generic amphetamine-based anorectics; likely commodity product with margin pressure.
Help build intelligence for Camallergy
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.